Eur Rev Med Pharmacol Sci 2019; 23 (2 Suppl): 201-209

DOI: 10.26355/eurrev_201904_17494

Spondylodiscitis: is really all well defined?

E. Marchionni, L. Marconi, D. Ruinato, E. Zamparini, A. Gasbarrini, P. Viale

Infectious Diseases Unit, Department of Medical and Surgical Sciences, Sant’Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy. elisa.marchionni@gmail.com


The term spondylodiscitis describes the infection of both the intervertebral disc space and the adjacent vertebrae. Pyogenic Vertebral Osteomyelitis (PVO) is more common in older patients (mean age 59-69 years) with a male preponderance (52-69%). Recent studies reported an alarming increase of incidence over the last 20 years, due to the increase of diagnostic sensibility, the increase of the average lifetime and to the consequent association of chronic disabling pathologies, of immunosuppression, of surgical or invasive procedure. Improvements in radiological diagnosis, surgical techniques, and management of antimicrobial therapy have greatly improved PVO clinical outcome, but morbidity remains significant mostly because of the delay of diagnosis. The non-specific features of this infection can lead to underestimate the patient conditions, ending to a significant delay in diagnosis, reported from 30 to 90 days, and consequently to severe impairments, such as spine deformity and permanent neurological deficit. The duration of medical treatment is not yet established, and further randomized trials are needed to define it.

Free PDF Download

To cite this article

E. Marchionni, L. Marconi, D. Ruinato, E. Zamparini, A. Gasbarrini, P. Viale
Spondylodiscitis: is really all well defined?

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 2 Suppl
Pages: 201-209
DOI: 10.26355/eurrev_201904_17494